Literature DB >> 6435741

Increased storage of iron and anaemia in rheumatoid arthritis: usefulness of desferrioxamine.

N Giordano, A Fioravanti, S Sancasciani, R Marcolongo, C Borghi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6435741      PMCID： PMC1443211          DOI： 10.1136/bmj.289.6450.961

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Nature of anaemia in rheumatoid arthritis. VI. Metabolism of endogenous iron.

Authors:  E T Owen; A A Lawson
Journal:  Ann Rheum Dis       Date:  1966-11       Impact factor: 19.103

2.  Role of the reticuloendothelial system in the anaemia of rheumatoid arthritis. A study using the 59Fe-labelled dextran model.

Authors:  R M Bennett; P J Holt; S M Lewis
Journal:  Ann Rheum Dis       Date:  1974-03       Impact factor: 19.103

3.  Reactions to total dose infusion of iron dextran in rheumatoid arthritis.

Authors:  K N Lloyd; P Williams
Journal:  Br Med J       Date:  1970-05-09

4.  The importance of iron in rheumatoid disease.

Authors:  D R Blake; N D Hall; P A Bacon; P A Dieppe; B Halliwell; J M Gutteridge
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

5.  [Anemia in rheumatoid polyarthritis. Value of serum ferritin for the estimation of iron stores].

Authors:  B Kitschke; A J Ciurana; L Bertrand; J Sany
Journal:  Nouv Presse Med       Date:  1982-12-18
  5 in total
  3 in total

1.  Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?

Authors:  H Pall; D R Blake; P Winyard; J Lunec; A Williams; P A Good; E E Kritzinger; A Cornish; R C Hider
Journal:  Br J Ophthalmol       Date:  1989-01       Impact factor: 4.638

Review 2.  Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment.

Authors:  G Vreugdenhil; A J Swaak
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 3.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.